| Literature DB >> 36129712 |
Rebecca Schnall1,2, Lisa M Kuhns3,4, Cynthia Pearson5, D Scott Batey6, Josh Bruce7, Marco A Hidalgo8, Sabina Hirshfield9, Patrick Janulis10, Haomiao Jia1, Asa Radix11, Uri Belkind11, Rafael Garibay Rodriguez1, Robert Garofalo3,4.
Abstract
Importance: HIV transmission rates in the United States have increased among men who have sex with men. However, there are no published randomized trials examining interventions to reduce sexual risk for HIV acquisition in males younger than 18 years. Objective: To determine the efficacy of MyPEEPS Mobile, a mobile-delivered HIV prevention intervention, to reduce sexual risk behavior in same-sex attracted young males. Design, Setting, and Participants: This was a national randomized clinical trial of the efficacy MyPEEPS Mobile vs a delayed intervention among males aged 13 to 18 years to prevent or reduce sexual risk for HIV acquisition. Study activities were completed through 4 study sites in Birmingham, Alabama; New York, New York; Seattle, Washington; and Chicago, Illinois. Study staff at each site met with participants in person or via video conferencing. Data were collected from June 1, 2018, to April 7, 2020, and analyzed from July to October 2021. Interventions: The MyPEEPS Mobile intervention contains 21 online psychoeducational and skill-building modules, which participants completed over a 3-month period. Participants randomized to the intervention group received access to MyPEEPS Mobile for the first 3 months, while those randomized to the delayed intervention group received access at their 9-month visit after data for the primary efficacy analysis had been collected. Main Outcomes and Measures: The self-reported primary outcome was change in the number of condomless anal sex acts between study conditions. Secondary outcomes were change in the number of sex partners, number of condomless anal sex partners, the number of sex acts while under the influence of substances, preexposure prophylactic uptake, nonoccupational postexposure prophylaxis use, and HIV and sexually transmitted infection testing.Entities:
Mesh:
Year: 2022 PMID: 36129712 PMCID: PMC9494195 DOI: 10.1001/jamanetworkopen.2022.31853
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure 1. Study Flow Diagram
Characteristics of 763 Participants in the MyPEEPS Mobile Randomized Clinical Trial, Overall and by Study Condition
| Characteristic | No. (%) | ||
|---|---|---|---|
| Overall (n = 763) | MyPEEPS intervention (n = 382) | Delayed MyPEEPS intervention (n = 381) | |
| Study site | |||
| Birmingham, Alabama | 98 (12.9) | 48 (12.7) | 50 (13.1) |
| Chicago, Illinois | 175 (23.0) | 87 (23.0) | 88 (23.1) |
| New York City, New York | 350 (46.1) | 176 (46.4) | 174 (45.7) |
| Seattle, Washington | 137 (18.0) | 68 (17.9) | 69 (18.1) |
| Age, mean (SD), y | 16.22 (1.4) | 16.23 (1.4) | 16.20 (1.4) |
| Gender identity | |||
| Male | 736 (97.0) | 368 (97.1) | 368 (96.8) |
| Genderqueer | 6 (0.8) | 4 (1.1) | 2 (0.5) |
| Nonbinary | 13 (1.7) | 4 (1.1) | 9 (2.4) |
| Other | 4 (0.5) | 3 (0.8) | 1 (0.3) |
| Sexual orientation | |||
| Only gay or homosexual | 406 (53.5) | 214 (56.5) | 192 (50.5) |
| Mostly gay or homosexual | 166 (21.9) | 74 (19.5) | 92 (24.2) |
| Bisexual | 161 (21.2) | 77 (20.3) | 84 (22.1) |
| Mostly heterosexual | 4 (0.5) | 2 (0.5) | 2 (0.5) |
| Only heterosexual | 2 (0.3) | 1 (0.3) | 1 (0.3) |
| Other | 20 (2.6) | 11 (2.9) | 9 (2.4) |
| Race | |||
| American Indian or Alaskan Native | 43 (5.7) | 20 (5.3) | 23 (6.0) |
| Asian | 72 (9.5) | 36 (9.5) | 36 (9.5) |
| Black or African American | 158 (20.8) | 75 (19.8) | 83 (21.8) |
| Native Hawaiian or other Pacific Islander | 11 (1.5) | 6 (1.6) | 5 (1.3) |
| White | 284 (37.4) | 132 (34.8) | 152 (39.9) |
| Multiracial | 94 (12.4) | 55 (14.5) | 39 (10.2) |
| Missing or unknown | 98 (12.9) | 55 (14.5) | 43 (11.3) |
| Ethnicity | |||
| Hispanic or Latino | 311 (40.9) | 169 (44.6) | 142 (37.3) |
| Not Hispanic or Latino | 449 (59.1) | 210 (55.4) | 239 (62.7) |
| Born outside United States | 54 (7.1) | 28 (7.4) | 26 (6.9) |
| Not a current student | 29 (3.8) | 12 (3.2) | 17 (4.5) |
| Highest education level | |||
| Sixth grade | 1 (0.1) | 1 (0.3) | 0 (0.0) |
| Seventh grade | 21 (2.8) | 9 (2.4) | 12 (3.2) |
| Eighth grade | 53 (7.0) | 25 (6.6) | 28 (7.4) |
| Some high school | 539 (71.3) | 266 (70.4) | 273 (72.2) |
| High school diploma/GED | 92 (12.2) | 47 (12.4) | 45 (11.9) |
| Some college | 50 (6.6) | 30 (7.9) | 20 (5.3) |
| Rural county of residence | 85 (11.2) | 41 (10.9) | 44 (11.6) |
| No primary care clinician | 206 (27.5) | 96 (25.5) | 110 (29.5) |
| Ever had HIV test | 252 (33.6) | 128 (34.0) | 124 (33.2) |
| Any sexual activity with another male | 517 (68.9) | 263 (69.8) | 254 (68.1) |
| Any anal sex acts with another male | 395 (52.0) | 203 (53.6) | 192 (50.4) |
| Combined insertive and receptive anal sex partners within past 3 mo, median (IQR), No. | 1 (0-2) | 1 (0-2) | 1 (0-2) |
Data were missing as follows: born outside the United States, 3 participants; not a current student, 1 participant; highest education level, 4 participants; rural county of residence, 2 participants; no primary care clinician, 10 participants; ever had HIV test, 10 participants; any sexual activity with another male, 10 participants; and combined No. of insertive and receptive anal sex partners within past 3 months, 11 participants.
Multivariate Results for Primary Outcomes
| Model | IRR (95% CI) | OR (95% CI) | ||||||
|---|---|---|---|---|---|---|---|---|
| Condomless sex acts | No. of sex partners | No. of CAS partners | Sex acts using substances | PrEP Use | nPEP | HIV Testing | STI Testing | |
| Time, IRR (95% CI) | ||||||||
| Baseline | [Reference] | [Reference] | [Reference] | [Reference] | [Reference] | [Reference] | [Reference] | [Reference] |
| 3-mo | 1.10 (0.74-1.63) | 0.80 (0.58-1.09) | 0.88 (0.60-1.28) | 0.86 (0.51-1.46) | 10.56 (1.91-58.44) | 0.63 (0.11-3.72) | 2.90 (1.77-4.76) | 0.82 (0.48-1.41) |
| 6-mo | 1.04 (0.69-1.59) | 0.99 (0.72-1.36) | 1.18 (0.81-1.72) | 1.09 (0.65-1.83) | 17.99 (3.10-104.46) | 2.71 (0.53-13.97) | 2.47 (1.49-4.10) | 0.76 (0.44-1.32) |
| 9-mo | 1.18 (0.79-1.77) | 0.89 (0.65-1.22) | 0.94 (0.64-1.38) | 1.32 (0.79-2.20) | 10.74 (1.88-61.40) | 0.43 (0.06-2.85) | 2.55 (1.53-4.24) | 0.76 (0.44-1.32) |
| Intervention, IRR (95% CI) | 1.56 (0.91-2.68) | 1.10 (0.81-1.49) | 1.27 (0.88-1.83) | 0.72 (0.32-1.62) | 0.36 (0.02-6.92) | 0.56 (0.04-8.62) | 1.18 (0.64-2.16) | 1.16 (0.62-2.18) |
| Intervention × time, IRR (95% CI) | ||||||||
| ×3-mo | 0.56 (0.32-0.99) | 1.16 (0.74-1.81) | 1.09 (0.64-1.87) | 0.91 (0.41-1.99) | 1.65 (0.12-23.19) | 1.81 (0.11-30.40) | 1.18 (0.59-2.35) | 1.45 (0.69-3.02) |
| ×6-mo | 0.61 (0.34-1.08) | 0.99 (0.63-1.54) | 0.73 (0.43-1.26) | 0.64 (0.28-1.46) | 5.31 (0.34-83.90) | 1.34 (0.10-18.70) | 1.28 (0.64-2.60) | 1.26 (0.59-2.69) |
| ×9-mo | 0.83 (0.47-1.47) | 1.20 (0.76-1.87) | 1.27 (0.74-2.17) | 1.51 (0.71-3.22) | 3.70 (0.23-58.41) | 0.76 (0.03-21.96) | 1.72 (0.85-3.47) | 1.54 (0.72-3.28) |
Abbreviations: CAS, condomless anal sex; IRR, incidence rate ratio; nPEP, nonoccupational postexposure prophylaxis; PrEP, preexposure prophylaxis; STI, sexually transmitted infection.
All models controlled for race and ethnicity, age, study site, and recruitment method (ie, online or in person).
Estimated Mean and SE for Condomless Sex Acts
| Time | Estimated mean (SE) | |||
|---|---|---|---|---|
| All | Black or African American Non-Hispanic | |||
| Intervention | Delayed intervention | Intervention | Delayed intervention | |
| Baseline | 1.42 (0.23) | 1.07 (0.15) | 0.71 (0.13) | 0.25 (0.04) |
| 3-mo | 0.88 (0.16) | 1.10 (0.17) | 0.40 (0.08) | 0.72 (0.13) |
| 6-mo | 0.94 (0.17) | 1.11 (0.17) | 0.26 (0.06) | 0.70 (0.14) |
| 9-mo | 1.39 (0.24) | 1.22 (0.20) | 0.90 (0.21) | 1.12 (0.21) |
Figure 2. Mean Number of Condomless Sex Acts
Whiskers indicate SDs.